Therapy Areas: Devices
Q'Apel Medical names new chief executive officer
23 July 2024 - Q'Apel Medical, a California-based private medical device company focused on neurovascular interventions, announced on Monday that it has named Jodie Fam as its new chief executive...
StimAire names new chief operating officer
23 July 2024 - StimAire, a US-based injectable neuromodulation company developing medical devices for obstructive sleep apnoea (OSA), announced on Monday that it has named Arthur Rascon as its new chi...
Renalys Pharma doses first Japanese patient in sparsentan registrational Phase III clinical trial for IgA nephropathy
18 July 2024 - Renalys Pharma, Inc, a Japan-based biopharmaceutical firm, announced on Thursday that it has dosed its first patient in Japan for its registrational Phase III clinical trial of sparsent...
Hyperfine secures FDA clearance for faster brain imaging software
17 July 2024 - Medical device company Hyperfine (Nasdaq: HYPR) announced on Wednesday that it has received FDA clearance for its ninth-generation AI-powered Swoop system software, significantly reduci...
CereVasc names new directors
17 July 2024 - CereVasc Inc, a US-based clinical-stage medical device company developing novel treatments for neurological diseases, announced on Tuesday the appointment of Shlomi Nachman and Timothy ...
Biorithm names new CEO
16 July 2024 - Biorithm, a Singapore-based global women's medical technology company involved in developing solutions for personalised connected maternity care, including Femom, a comprehensive r...